Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium.

Kimura, H; Zhang, L; Zhao, M; Hayashi, K; Tsuchiya, H; Tomita, K; Bouvet, M; Wessels, J; Hoffman, R M

Kimura, H; Zhang, L; Zhao, M; Hayashi, K; Tsuchiya, H; Tomita, K; Bouvet, M; Wessels, J; Hoffman, R M.

Affiliation

Kimura H; AntiCancer, Inc., San Diego, CA, USA.

Cell Prolif ; 43(1): 41-8, 2010 Feb.

Article in En | MEDLINE | ID: mdl-19922490

Subject(s)

Glioma/therapy; Salmonella typhimurium/physiology; Spinal Cord Neoplasms/therapy; Animals; Biological Therapy/methods; Cell Line, Tumor; DNA-Binding Proteins/genetics; DNA-Binding Proteins/metabolism; Disease Models, Animal; Female; Humans; Injections, Spinal; Mice; Mice, Nude; Nuclear Proteins/genetics; Nuclear Proteins/metabolism; Organisms, Genetically Modified; Paralysis/etiology; Paralysis/therapy; Salmonella typhimurium/genetics; Salmonella typhimurium/growth & development; Spinal Cord Neoplasms/pathology; Survival Analysis; Xenograft Model Antitumor Assays

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Salmonella typhimurium / Spinal Cord Neoplasms / Glioma Type of study: Etiology_studies Language: En Journal: Cell Prolif Year: 2010 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google